Jobs / United States / Relay Therapeutics INC

Relay Therapeutics INC

Director, Clinical Operations

Cambridge, MA Posted 11 days ago

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Skills this job asks for

TranslationLeadershipRecruitmentComplianceGoogle Cloud

Add your CV (free) to see which of these your CV is missing.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordUSCIS Data Hub records 1 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
USCIS Data Hub records 1 H-1B approvals for this employer in FY2023 — older 2023 data; no recent Department of Labor filings (Oct 2025 – Jun 2026) were found for it. Source: US Department of Labor visa filings (LCA) (US Department of Labor (OFLC), plus USCIS H-1B Employer Data Hub).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

The Opportunity: As Director, Clinical Operations – Global Study Lead, you will be accountable for the end-to-end planning and execution of one or more global studies within Relay Tx’s breast cancer (BC) program. You will lead cross-functional study teams and CRO partners to deliver registrational-quality studies with speed, rigor and data integrity. You will be an integrated member of the BC clinical development team, bringing operational insight to study design and program strategy, and translating Relay’s innovative science into impactful medicines for patients with breast cancer. You will report to the Vice President, Clinical Operations. Your Role: • You will serve as the Global Study Lead, accountable for the delivery of assigned BC studies from protocol concept through study start-up, enrollment, database lock and clinical study report, on time, on budget and to quality. • You will lead the cross-functional study team (Clinical Science, Medical, Biostatistics, Data Management, Clinical Supply, Regulatory, Safety, Quality and Translational), setting clear priorities, driving decisions and escalating risks appropriately. • You will bring operational and feasibility input to protocol design, country and site selection, and enrollment strategy, ensuring study plans are aligned with the BC clinical development strategy and corporate goals. • You will own the study’s integrated timelines, budget, forecasts, risk and mitigation plans, and key performance metrics, and provide clear, data-driven status updates to program and senior leadership. • You will select, contract and oversee CROs and specialty vendors (e.g., central lab, imaging, IRT, eCOA), holding partners accountable for performance and quality through governance and active issue management. • You will drive enrollment and site performance across a global footprint (North America, Europe and other regions), using data and creative recruitment and retention approaches to accelerate timelines. • You will build and maintain strong relationships with investigators, key opinion leaders, site staff and cooperative groups in the breast oncology community, and be able to explain complex scientific and operational topics to these stakeholders. • You will ensure inspection readiness and compliance with GCP, ICH, and applicable global regulations, including oversight of the Trial Master File, monitoring strategy, protocol deviations and corrective/preventive actions. • You will contribute the Clinical Operations sections of key regulatory and study documents (e.g., protocols and amendments, IND/CTA submissions, briefing packages, NDA/MAA components, annual reports, study postings and clinical study reports). • You will partner with Clinical Operational Excellence to apply and improve study systems, processes and SOPs, and share lessons learned across the BC program and the broader Clinical Operations team. • You will lead, coach and develop clinical study managers, clinical trial associates and other study team members, and serve as a leadership role model within Clinical Development Operations. Your Background: • You bring 10+ years of experience in the biopharma or CRO industry, including significant experience leading global studies as a study lead or equivalent. • You have led global Phase 2 and/or Phase 3 oncology studies end to end; experience with registrational studies is strongly preferred. • You have breast cancer or solid tumor oncology experience; familiarity with endocrine therapy, targeted therapy combinations, or the metastatic breast cancer treatment landscape is a plus. • You have a track record of hands-on CRO and vendor oversight in an outsourced model, including contracting, budget management and performance governance. • You have strong, curre

Apply on employer site ↗